Recent advances in targeted genome engineering in mammalian systems
Authors:
- 10 July 2012
- journal article
- review article
- Published by Wiley in Biotechnology Journal
- Vol. 7 (9) , 1074-1087
Abstract
Targeted genome engineering enables researchers to disrupt, insert, or replace a genomic sequence precisely at a predetermined locus. One well‐established technology to edit a mammalian genome is known as gene targeting, which is based on the homologous recombination (HR) mechanism. However, the low HR frequency in mammalian cells (except for mice) prevents its wide application. To address this limitation, a custom‐designed nuclease is used to introduce a site‐specific DNA double‐strand break (DSB) on the chromosome and the subsequent repair of the DSB by the HR mechanism or the non‐homologous end joining mechanism results in efficient targeted genome modifications. Engineered homing endonucleases (also called meganucleases), zinc finger nucleases, and transcription activator‐like effector nucleases represent the three major classes of custom‐designed nucleases that have been successfully applied in many different organisms for targeted genome engineering. This article reviews the recent developments of these genome engineering tools and highlights a few representative applications in mammalian systems. Recent advances in gene delivery strategies of these custom‐designed nucleases are also briefly discussed.Keywords
This publication has 104 references indexed in Scilit:
- Directed Evolution of Adeno-associated Virus for Enhanced Gene Delivery and Gene Targeting in Human Pluripotent Stem CellsMolecular Therapy, 2012
- In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger NucleasesStem Cells, 2011
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Gene Editing of Human Embryonic Stem Cells via an Engineered Baculoviral Vector Carrying Zinc-finger NucleasesMolecular Therapy, 2011
- Meganuclease-mediated Inhibition of HSV1 Infection in Cultured CellsMolecular Therapy, 2011
- TAL effectors are remote controls for gene activationCurrent Opinion in Microbiology, 2011
- Self-complementary AAV mediates gene targeting and enhances endonuclease delivery for double-strand break repairGene Therapy, 2010
- Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAsMolecular Therapy, 2010
- Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem CellsCell Stem Cell, 2009
- Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene ModificationMolecular Cell, 2008